Anthem Biosciences Ltd

Anthem Biosciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on Anthem Biosciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Anthem Biosciences Ltd Share Price Chart

ANTHEM at 10 Jul 2026 06:03 PM Pharmaceuticals

754.70 +2.70(+0.36%)

Lowest Today 749.00

Highest Today 759.50

Today's Open 753.20

Prev. Close 752.00

52 Week High 873.50

52 Week Low 579.15

Anthem Biosciences Ltd Fundamentals

Traded Volume: 3,34,847

Market Cap(Cr): 42,504.34

Avg Traded Price 755.07

1 Year return %

Upper Circuit 759.5

Lower Circuit 749

P/E TTM 72.00

P/B Ratio 13.885

Traded Value(Cr) 2527.09

EPS TTM 10.508

Book value/Share 54.160

Dividend Yield 1Y 0.27%

Anthem Biosciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Anthem Biosciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Anthem Biosciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -2.29%

1M -3.03%

3M +4.78%

1Y 0.00%

YTD +17.85%

Anthem Biosciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Anthem Biosciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 3.80L

Day Before Yesterday 11.42L

1W Avg 5.00L

1M Avg 5.55L

3M Avg 4.78L

Anthem Biosciences Ltd Technical Details

Anthem Biosciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 749

Support 2 744

Support 3 739

Pivot Point : 754

Resistance 1 760

Resistance 2 765

Resistance 3 770

Anthem Biosciences Ltd Corporate Actions

Anthem Biosciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Anthem Biosciences Ltd’s capital allocation strategies.

All

Ex-Date 25-Jun-2026 Type D Description 2.00/share@100.00% Record Date 26-Jun-2026 Ratio 100.00

Dividends

Announcement Date 25-Jun-2026 Ex Dividend Date 25-Jun-2026 Dividend(%) 100

Bonus

No Bonus has been declared by ANTHEM

Splits

No Split has been declared by ANTHEM

Others

Rights No Rights has been declared by ANTHEM

Anthem Biosciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Anthem Biosciences Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Anthem Biosciences Ltd's relative performance and valuation against major competitors.

Stock Name Glenmark Pharmaceuticals Ltd ₹2282.90 (+0.69%) M. Cap (Cr) 644.24 1 Yr Return (%) +25.52% P/E (TTM) 47.31 PB Ratio 6.13

Stock Name Abbott India Ltd ₹27165.00 (+1.48%) M. Cap (Cr) 577.26 1 Yr Return (%) -21.01% P/E (TTM) 37.19 PB Ratio 12.09

Stock Name Ipca Laboratories Ltd ₹1787.90 (+0.99%) M. Cap (Cr) 453.60 1 Yr Return (%) +22.84% P/E (TTM) 39.75 PB Ratio 5.63

Stock Name Anthem Biosciences Ltd ₹754.70 (+0.36%) M. Cap (Cr) 425.04 1 Yr Return (%) NaN% P/E (TTM) 71.82 PB Ratio 13.97

Stock Name Ajanta Pharma Ltd ₹3348.60 (+1.24%) M. Cap (Cr) 418.36 1 Yr Return (%) +27.46% P/E (TTM) 39.61 PB Ratio 9.24

Stock Name Glaxosmithkline Pharmaceuticals Ltd ₹2438.20 (-0.09%) M. Cap (Cr) 413.05 1 Yr Return (%) -26.32% P/E (TTM) 39.87 PB Ratio 18.22

Stock Name Gland Pharma Ltd ₹2479.40 (+0.40%) M. Cap (Cr) 409.00 1 Yr Return (%) +32.05% P/E (TTM) 39.81 PB Ratio 3.95

Anthem Biosciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Anthem Biosciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2026 889.42 Mar 2025 439.84 Mar 2024 164.41 Mar 2023 318.98 Mar 2022 333.35

PARTICULARS Investing Activities Mar 2026 -742.00 Mar 2025 -246.31 Mar 2024 -191.76 Mar 2023 -377.91 Mar 2022 -205.78

PARTICULARS Financing Activities Mar 2026 -43.55 Mar 2025 -66.42 Mar 2024 -131.59 Mar 2023 52.85 Mar 2022 180.68

PARTICULARS Net Cash Flow Mar 2026 103.60 Mar 2025 127.10 Mar 2024 -158.95 Mar 2023 -6.07 Mar 2022 308.24

Anthem Biosciences Ltd Shareholding Pattern

This shows the ownership breakdown of Anthem Biosciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 74.68%

Public 12.48%

Other Institutions 1.43%

FII 1.28%

Mutual Funds 10.12%

About Anthem Biosciences Ltd

Anthem Biosciences Limited was originally incorporated as Anthem Biosciences Private Limited, dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to Anthem Biosciences Limited and a Certificate of Incorporation was issued by RoC on December 10, 2024.The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries.The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I - Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 2018-19. In year 2020, Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024, Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects. Company launched the initial public offering of 59,575,319 equity shares of face value of Rs 2 each by raising funds through offer for sale aggregating to Rs 3395 Crore in July, 2025. The Company expanded the fermentation capacity to 140 KL at the Unit II in 2025. The Unit IV greenfield expansion project commissioned in Harohalli, Bengaluru in 2026. The Company expanded custom synthesis capacity from 270 KL to approximately 425 KL and increased fermentation capacity from 80 KL to approximately 180 KL (including NeoAnthem - Unit III) across its facilities during 2026.

Chairman & MD & CEO

Ajay Bhardwaj

Registered office 49 F1 & F2 Canara Bank Road, Bommasandra Industrial Area, Bangalore, Karnataka, 560099

FAX :+91 080 6672 4000

Background

Incorporation Year 2006

Face Value ₹2.00

Market Lot 1

Anthem Biosciences Ltd Latest News

VIEW MORE NEWS

FAQs on Anthem Biosciences Ltd